-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1 | 1722.55 | 1736.80 | 4 |
| 2 | 1722.05 | 1737.00 | 2 |
| 1 | 1722.00 | 1738.00 | 51 |
| 2 | 1721.00 | 1750.00 | 20 |
| 34 | 1720.00 | 1759.00 | 5 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1 | 1722.55 | 1736.80 | 4 |
| 2 | 1722.05 | 1737.00 | 2 |
| 1 | 1722.00 | 1738.00 | 51 |
| 2 | 1721.00 | 1750.00 | 20 |
| 34 | 1720.00 | 1759.00 | 5 |
| 0 | Total | Total | 0 |
| Open | 1,729.80 |
| Previous Close | 1,736.80 |
| Volume | 38,711.00 |
| Value (Lacs) | 670.16 |
| VWAP | 1,723.59 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 13,159 |
| High | 1,737.70 |
| Low | 1,708.20 |
| UC Limit | 2,084.10 |
| LC Limit | 1,389.50 |
| 52 Week High | 2,395.00 |
| 52 Week Low | 1,599.00 |
| Face Value | 2.00 |
| All Time High | 2,641.00 |
| All Time Low | 34.80 |
| 20D Avg Volume | 77,129 |
| 20D Avg Delivery(%) | 44.44 |
| Book Value Per Share | 415.64 |
| Dividend Yield | 0.35 |
| TTM EPS See historical trend | 80.74 (+19.08% YoY) |
| TTM PE See historical trend | 21.44 (Low PE) |
| P/B See historical trend | 4.17 (Average P/B) |
| Sector PE | 39.32 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
7 out of 12 years Caplin Point Laboratories has given negative returns in February.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| February | 28.98% (2015) | 8.75% | -22.07% (2016) | -8.95% | -1.57% |
Caplin Labs Standalone December 2025 Net Sales at Rs 189.22 crore, up 2.15% Y-o-Y Feb 09 2026 11:29 AM
Trade Spotlight: How should you trade Hero MotoCorp, Sarda Energy, Max Financial Services, Hindalco, Larsen & Toubro, and others on February 5? Feb 05 2026 03:49 AM
Caplin Point shares up 2% after USFDA approval for Methylprednisolone Acetate injection Jan 28 2026 09:21 AM
Caplin Labs Standalone September 2025 Net Sales at Rs 175.18 crore, down 15.75% Y-o-Y Nov 12 2025 08:30 AM
if the stock does not hold 1650 then it can test 1475. View more
Posted by : national.pride
Posted by : The Fixed Income
Repost this message
built with love in india, the fixed income is a sebi registered bond investment platform. it empowers over 2,00,000 investors to grow with stability. whether it’s corporate bonds, government bonds, fixed deposits, or more, our platform helps you build a solid financial foundation with predictable, stable returns. explore now: https://tinyurl.com/fihopa
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 396355 | Price 1899.6 | % Traded 0.54 |
| Qty 396355 | Price 1901.28 | % Traded 0.54 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
